Leuko Labs’ technology monitors white blood cell levels non-invasively, helping immunosuppressed and chemotherapy patients avoid infections and febrile neutropenia.
Shining light into the skin surrounding the fingernail, Leuko’s device images the blood cells flowing through superficial capillaries to determine if white cell levels are dangerously low. There is no need to extract blood. Millions of immunosuppressed patients can now be tested more frequently, improving their quality of life and clinical outcomes.
Non-invasive white cell count prototype
The company is a spin-out from the 2016 project, Non-invasive white cell count prototype.